Johnson & Johnson (JNJ) financials · Finance & Quant Society

Balance sheet (USD)	Q2 2026 ended Jun 28, 2026	Q1 2026 ended Mar 29, 2026	Q4 2025 ended Dec 28, 2025	Q3 2025 ended Sep 28, 2025	Q2 2025 ended Jun 29, 2025	Q1 2025 ended Mar 30, 2025	Q4 2024 ended Dec 29, 2024	Q3 2024 ended Sep 29, 2024
Cash and equivalents	20.42B	21.69B	19.71B	18.23B	18.58B	38.47B	24.11B	19.98B
Short-term investments	336.00M	363.00M	393.00M	331.00M	303.00M	307.00M	417.00M	317.00M
Receivables	19.05B	17.72B	17.18B	17.61B	17.85B	16.02B	14.84B	16.17B
Inventory	15.14B	14.58B	14.19B	14.15B	13.41B	12.66B	12.44B	12.60B
Total current assets	59.77B	59.17B	55.62B	54.61B	54.50B	71.55B	55.89B	53.25B
Property, plant and equipment	23.58B	23.27B	23.17B	22.34B	21.95B	20.87B	20.52B	20.48B
Goodwill and intangibles	96.71B	97.62B	99.17B	96.78B	97.95B	81.22B	81.82B	84.29B
Total assets	201.06B	200.89B	199.21B	192.82B	193.39B	193.67B	180.10B	178.29B
Accounts payable	9.22B	10.46B	11.99B	9.63B	9.46B	9.54B	10.31B	8.95B
Total current liabilities	54.90B	57.72B	54.13B	50.87B	54.18B	56.90B	50.32B	51.76B
Long-term debt	37.34B	37.53B	39.44B	39.41B	39.23B	38.35B	30.65B	31.29B
Total liabilities	116.09B	119.71B	117.67B	113.54B	114.92B	115.56B	108.61B	108.13B
Retained earnings	171.66B	169.16B	168.98B	167.28B	165.37B	162.63B	155.79B	155.18B
Shareholders' equity	84.97B	81.19B	81.54B	79.28B	78.47B	78.11B	71.49B	70.16B
Total debt	49.04B	54.99B	56.43B	45.80B	50.76B	52.25B	42.63B	35.75B
Net debt	28.61B	33.30B	36.72B	27.56B	32.18B	13.78B	18.53B	15.77B

From Johnson & Johnson's 10-K and 10-Q filings with the SEC. Fourth quarters, and quarters where the company only reported year-to-date totals, are worked out by subtracting the earlier quarters. Fiscal years are the company's own, so they may not match the calendar. A blank cell means the company did not report that line. New to this? Read balance sheet or reading a 10-K.

Johnson & Johnson

Charts

Report a problem